Jayant Nagesh Banavaliker

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial

Surendra K. Sharma, Kiran Katoch, Rohit Sarin et al. · Scientific Reports · 2017 · 109 citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D

Jaishriram Rathored, Surendra K. Sharma, Bhagteshwar Singh et al. · The International Journal of Tuberculosis and Lung Disease · 2012 · 89 citations

Medicine, Genetics, Infectious Diseases +17

Incidence and Risk Factors for Extensively Drug-Resistant Tuberculosis in Delhi Region

Chhavi Porwal, Amit Kaushik, Nayani Makkar et al. · PLoS ONE · 2013 · 47 citations · Full text

Public Health, Infectious Diseases, Antimicrobial Pharmacotherapy +16

Comparison of spoligotyping, mycobacterial interspersed repetitive units typing and IS6110-RFLP in a study of genotypic diversity of Mycobacterium tuberculosis in Delhi, North India

Mandira Varma‐Basil, Sujeet Kumar, Jyoti Arora et al. · Memórias do Instituto Oswaldo Cruz · 2011 · 45 citations · Full text

Life Sciences, Genetics, Microbiology +14

Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis

Abhimanyu Abhimanyu, Irengbam Rocky Mangangcha, Pankaj Jha et al. · Infection Genetics and Evolution · 2011 · 42 citations

Life Sciences, Genetics, Immunology +13